Filing Details

Accession Number:
0000950170-24-062008
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-17 18:41:24
Reporting Period:
2024-05-17
Accepted Time:
2024-05-17 18:41:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1820190 Scilex Holding Co SCLX Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1994406 Jay Chun C/O Scilex Holding Company
960 San Antonio Road
Palo Alto CA 94303
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-05-17 57,500 $0.90 102,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11 Indirect By Child
Footnotes
  1. Open market purchase by the reporting person of 57,500 shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock reported represents an aggregate number of shares purchased in multiple open market transactions over a range of sales prices.
  2. Reflects the weighted average price of the shares of Common Stock purchased on the open market in multiple transactions on May 17, 2024 at prices ranging from $0.8978 to $0.8998 per share, inclusive. The amount reflected has been rounded to 4 decimal points.
  3. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of such shares of Common Stock purchased at each separate price within such range.